These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36125491)

  • 1. Risk factors and prognostic factors for pulmonary large cell neuroendocrine carcinoma with brain metastasis.
    Chen X; Huang Y; Chen F; She H; Chen X
    Cancer Med; 2023 Feb; 12(4):4087-4099. PubMed ID: 36125491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and Validation of Prognostic Nomograms for Patients with Metastatic Pulmonary Large Cell Neuroendocrine Carcinoma.
    Chen X; Lai X; Huang Y; Deng C
    Cancer Control; 2024; 31():10732748241274195. PubMed ID: 39134429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors, survival analysis, and nomograms for distant metastasis in patients with primary pulmonary large cell neuroendocrine carcinoma: A population-based study.
    Song Z; Zou L
    Front Endocrinol (Lausanne); 2022; 13():973091. PubMed ID: 36329892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
    Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
    BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma.
    He Y; Liu H; Wang S; Chen Y
    PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
    Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
    BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development and Validation of A Prognostic Nomogram to Guide Decision-making 
in Lung Large Cell Neuroendocrine Carcinoma].
    Chen S; Li S; Wang Z; Zhang W; Zhou L; Jiao W
    Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):487-496. PubMed ID: 37653012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Clinical Nomogram for Predicting Cancer-Specific Survival in Pulmonary Large-Cell Neuroendocrine Carcinoma Patients: A Population-Based Study.
    Ma H; Xu Z; Zhou R; Liu Y; Zhu Y; Chang X; Chen Y; Zhang H
    Int J Gen Med; 2021; 14():7299-7310. PubMed ID: 34737624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic nomograms for newly diagnosed intrahepatic cholangiocarcinoma with brain metastasis: A population-based analysis.
    Liu Z; Yi J; Yang J; Zhang X; Wang L; Liu S
    Exp Biol Med (Maywood); 2022 Sep; 247(18):1657-1669. PubMed ID: 35946168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma.
    Hu C; Yang J; Huang Z; Liu C; Lin Y; Tong Y; Fan Z; Chen B; Wang C; Zhao CL
    BMC Cancer; 2020 Jun; 20(1):494. PubMed ID: 32487048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic Cancer: A Population-Based Analysis.
    Zhang W; Ji L; Wang X; Zhu S; Luo J; Zhang Y; Tong Y; Feng F; Kang Y; Bi Q
    Front Endocrinol (Lausanne); 2021; 12():752176. PubMed ID: 35356148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and predictive models for patients with lung large cell neuroendocrine carcinoma: Based on SEER database.
    Li W; Huang Q; He X; He Q; Lai Q; Yuan Q; Deng Z
    Clin Respir J; 2024 Apr; 18(4):e13752. PubMed ID: 38606731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis pattern and prognosis of large cell neuroendocrine carcinoma: a population-based study.
    Jiang T; Sun H; Li N; Jiang T
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13511-13521. PubMed ID: 37498395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of the diagnostic and prognostic nomograms for pancreatic cancer with bone metastasis.
    Liu Z; Liu H; Wang D
    Sci Rep; 2022 Oct; 12(1):18085. PubMed ID: 36302941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized prognostic prediction tool for high-grade neuroendocrine cervical cancer: a SEER database analysis and single-center validation.
    Chen X; Shi W; Wang C; Zhu H
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17395-17404. PubMed ID: 37853082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel nomogram predicting cancer-specific survival in small cell lung cancer patients with brain metastasis.
    Rong YT; Zhu YC; Wu Y
    Transl Cancer Res; 2022 Dec; 11(12):4289-4302. PubMed ID: 36644187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram to predict overall survival in patients with primary bladder neuroendocrine carcinoma: a population-based study.
    Li S; Liu X; Weipeng L; Fu B
    Future Oncol; 2022 Dec; 18(38):4171-4181. PubMed ID: 36651444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic factors, and two nomograms for endometrial cancer patients with bone metastasis: A large cohort retrospective study.
    Yang F; Zhao R; Huang X; Wang Y
    Medicine (Baltimore); 2021 Sep; 100(36):e27185. PubMed ID: 34516519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early death incidence and prediction in stage IV large cell neuroendocrine carcinoma of the lung.
    Xing H; Wu C; Zhang D; Zhang X
    Medicine (Baltimore); 2024 Sep; 103(37):e39294. PubMed ID: 39287289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcome and prognostic analysis of advanced large cell neuroendocrine carcinoma of the lung.
    Xia L; Wang L; Zhou Z; Han S
    Sci Rep; 2022 Oct; 12(1):16562. PubMed ID: 36195623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.